TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm Solutions” or the “Company”) announced today it had closed the first tranche of its previously announced private placement equity financing.  Under the closing of the first tranche, the Company issued 3,300,000 units at a price of $0.05 per unit, for gross proceeds of $165,000.  Each unit was comprised of one common share of the Company and one common share purchase warrant exercisable for two years for an additional share at a price of $0.07.  For further information regarding the financing, please see the Company’s press release that was issued on July 11, 2014.  The gross proceeds from the financing will be used towards the development of next generation wireless ECG device products and expanded promotion of the GEMSTM WIN launch.  The shares and warrants issued by the Company are subject to a four month hold period which expires on November 25, 2014.  The Company also confirmed that it will continue its current private placement equity financing offer.